PHILADELPHIA, PA--(Marketwired - May 12, 2016) - Simshabs Capital Partners is happy to announce that it will be proceeding with development of a 68,000 square-foot facility for a major client in the pharmaceutical industry.
The site is to be chosen within the next several weeks and will be located in one of the Mid-Atlantic states, preferably New Jersey or Pennsylvania. The use will be a combination of office and research & development. Such will play a role in the advancement of research in regard to biotechnology as well as development of drugs for diseases such as Parkinson's, epilepsy and several other fields.
The project is expected to encompass a number of priorities including Class A facilities, green technologies and energy conservation measures. The intention is to create a harmonious environment that will function at the highest level of technological standards while meeting the expectations of the employees and management in their day-to-day working environment.
For more information, please contact us at info@simshabscapital.com
Contact Information:
Simshabs Capital Partners, Ltd.
info@simshabscapital.com